In This Section      

Chlamydia Screening in Women

EHP, Priority Partners, and USFHP. Female members 16-24 years of age.

Women who were identified as sexually active and had at least one chlamydia test in the measurement year. Report two age stratifications and a total rate:

  • 16–20 years (Women)
  • 21–24 years (Women)
  • Total (Women)

Best Practice and Measure Tips

  • Chlamydia screening may not be captured via claims if the service is performed and billed under prenatal and postpartum global billing.
  • May be either a urine analysis or vaginal swab from the same ThinPrep used for the Pap smear. Samples must be sent to the lab vendor for analysis.
  • Note should indicate the date the test was performed and the result or finding.

Measure Exclusions

Required Exclusions: Hospice

Optional Exclusions: Any time during the measurement year:

  • If a member qualified for the measure from a pregnancy test alone, they’ll be excluded if they have one of the following on the date of the pregnancy test or six days after the pregnancy test:
    • A prescription for isotretinoin (Retinoid medications)
    • An X-ray

Measure Codes

  • Chlamydia Screening Test
    • CPT/CPT II 87110, 87270, 87320, 87490-92, 87810